XHEvsXBIETF Comparison
VS
State Street SPDR S&P Health Care Equipment ETF (XHE) and State Street SPDR S&P Biotech ETF (XBI) belong to the same industry segment: US Health Care. Both ETFs have the same top 2 sector exposures: Healthcare and Finance. Both XHE and XBI have the same Total Expense Ratio (TER) of 0.35%. XHE is up 3.73% year-to-date (YTD) with +$13M in YTD flows. XBI performs better with 30.8% YTD performance, and +$806M in YTD flows. Run a side-by-side ETF comparison of XHE and XBI below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
Find out how industry players manage ETF portfolios. Discover our library of Model portfolios
XHE vs XBI performance and flow charts
Performance
Cumulative Flows
Historic performance and flows
Data as of 09/09/2026
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | XHE XBI | -3.04%+0.84% | +10.11%+21.41% | +3.73%+30.80% | +10.83%+68.54% | +9.19%+103.54% | -30.39%+20.80% |
| Flows | XHE XBI | +$5M+$372M | +$14M+$1.20B | +$13M+$806M | +$2M+$1.60B | -$264M-$130M | -$380M+$1.59B |
Volatility and drawdown
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | XHE XBI | +24.07%+29.80% | +22.81%+27.95% | +22.21%+28.29% | +24.83%+32.91% |
| Max drawdown | XHE XBI | -5.67%-10.46% | -18.20%-10.46% | -24.35%-32.94% | -49.37%-53.28% |
| Max drawdown duration | XHE XBI | 21d40d | 207d40d | 565d331d | 1771d1622d |
Trading data
XHE | XBI | |
Last sale 9/10/2026 at 1:30 PM | $89.53 | $156.82 |
| Previous close 09/09/2026 | $91.41 | $159.38 |
| Consolidated volume 09/09/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Replication quality
Data as of August 31, 2026
1-year trailing difference
Create an account to view replication metrics
Join for free
XHE | XBI | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
Advertisement
Main metrics
Last update 9/10/2026 at 1:30 PM
Live
Closed
XHE | XBI | |
|---|---|---|
| Last price | $89.53 | $156.82 |
| 1D performance | -2.06% | -1.61% |
| AuM | $173.68 M | $11.00 B |
| E/R | 0.35% | 0.35% |
Characteristics
XHE | XBI | |
|---|---|---|
| Management strategy | Passive | Passive |
| Provider | State Street Investment Management | State Street Investment Management |
| Benchmark | S&P Health Care Equipment Select Industry Index | S&P Biotechnology Select Industry Index |
| N° of holdings | 66 | 149 |
| Asset class | Equities | Equities |
| Trailing 12m distribution yield | Join | Join |
| Inception date | January 26, 2011 | January 31, 2006 |
| ESG | No | No |
Advertisement
Exposure
Countries
XHE
USA
93.56%
Other
6.44%
XBI
USA
95.3%
Other
4.7%
Sectors
XHE
Healthcare
98.72%
Other
1.28%
XBI
Healthcare
99.41%
Other
0.59%
Advertisement
Diversification
XHE
Total weight of top 15 holdings out of 15
30.19%
XBI
Total weight of top 15 holdings out of 15
20.29%
Top 15 holdings
Data as of July 31, 2026
XHE
AtriCure, Inc.
2.14%
Glaukos Corp.
2.13%
Dentsply Sirona, Inc.
2.08%
Enovis Corp.
2.07%
Integer Holdings Corp.
2.07%
Butterfly Network, Inc.
2.06%
Neogen Corp.
2.05%
Artivion, Inc.
2.05%
Baxter International, Inc.
2.01%
CONMED Corp.
1.99%
Merit Medical Systems, Inc.
1.98%
QuidelOrtho Corp.
1.94%
ICU Medical, Inc.
1.88%
Tandem Diabetes Care, Inc.
1.88%
Inspire Medical Systems, Inc.
1.85%
XBI
Apogee Therapeutics, Inc.
1.65%
Oruka Therapeutics, Inc.
1.53%
Dianthus Therapeutics, Inc.
1.42%
Erasca, Inc.
1.38%
Twist Bioscience Corp.
1.37%
Kymera Therapeutics, Inc.
1.34%
Spyre Therapeutics, Inc.
1.33%
Revolution Medicines, Inc.
1.32%
CG Oncology, Inc.
1.32%
Protagonist Therapeutics, Inc.
1.31%
Praxis Precision Medicines, Inc.
1.30%
Regeneron Pharmaceuticals, Inc.
1.29%
Cogent Biosciences, Inc.
1.26%
Natera, Inc.
1.26%
Arrowhead Pharmaceuticals, Inc.
1.22%
Frequently asked questions about XHE and XBI
How have the XHE and XBI ETFs performed in 2026?
As of September 9, 2026, XHE is up 3.73% year-to-date (YTD), while XBI has returned 30.8%. That puts XBI better performer ahead so far this year.
Which ETF is attracting more investor money: XHE or XBI?
Year-to-date, the XHE ETF saw +$13M in flows, compared to +$806M for XBI.
Which ETF is more volatile: XHE or XBI?
Over the past year, XHE had a volatility of 22.81%, while XBI experienced 27.95%.
Which ETF is bigger: XHE or XBI?
As of September 9, 2026, XHE holds $173.68 M in assets under management (AUM), while XBI manages $11.00 B.
What sectors do the XHE and XBI ETFs invest in?
XHE leans toward sectors like Healthcare. Meanwhile, XBI focuses on Healthcare.
What are the top holdings of the XHE ETF and XBI ETF?
XHE top holdings include AtriCure, Inc., Glaukos Corp. and Dentsply Sirona, Inc.. XBI holds in its top three: Apogee Therapeutics, Inc., Oruka Therapeutics, Inc. and Dianthus Therapeutics, Inc..
Which ETF is more diversified: XHE or XBI?
XHE holds 66 securities with 30.19% of its assets in the top 15. XBI has 151 securities and a top 15 weight of 20.29%.
Advertisement
Latest news about XHE & XBI
Small-Cap Biotech ETFs: High-Risk, High-Reward Opportunities
September 18, 2025
XBI
Are Biotechnology ETFs In the Midst of a Comeback?
August 20, 2025
XBI
Two biotech ETFs to watch for the rest of 2022 and beyond
September 13, 2022
XBI
Biotech ETFs – Investing in Health Innovation
July 21, 2022
XBI
Advertisement
Advertisement
